{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:55:01Z","timestamp":1781765701137,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T00:00:00Z","timestamp":1661558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5RO1HD070795-06A1"],"award-info":[{"award-number":["5RO1HD070795-06A1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5U01DA04439902"],"award-info":[{"award-number":["5U01DA04439902"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 HD070795-06A1"],"award-info":[{"award-number":["R01 HD070795-06A1"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1038\/s41372-022-01487-2","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T13:02:59Z","timestamp":1661605379000},"page":"271-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial"],"prefix":"10.1038","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6191-7697","authenticated-orcid":false,"given":"Gary","family":"Peltz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2708-6142","authenticated-orcid":false,"given":"Lauren M.","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4518-1709","authenticated-orcid":false,"given":"Susan","family":"Adeniyi-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4363-5260","authenticated-orcid":false,"given":"Carol","family":"Cohane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6633-3295","authenticated-orcid":false,"given":"David","family":"Drover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Shafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5491-3081","authenticated-orcid":false,"given":"Manhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Govindaswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4068-0330","authenticated-orcid":false,"given":"Priya","family":"Jegatheesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Argani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5074-0141","authenticated-orcid":false,"given":"Walter K.","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,27]]},"reference":[{"key":"1487_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1001\/jamapediatrics.2018.5044","volume":"173","author":"T Disher","year":"2019","unstructured":"Disher T, Gullickson C, Singh B, Cameron C, Boulos L, Beaubien L, et al. Pharmacological treatments for neonatal abstinence syndrome: a systematic review and network meta-analysis. JAMA Pediatr. 2019;173:234\u201343.","journal-title":"JAMA Pediatr"},{"key":"1487_CR2","doi-asserted-by":"publisher","unstructured":"Patrick SW, Barfield WD, Poindexter BB, Committee on fetus and newborn, committee on substance use and prevention. neonatal opioid withdrawal syndrome. Pediatrics 2020 Nov;146: https:\/\/doi.org\/10.1542\/peds.2020-029074.","DOI":"10.1542\/peds.2020-029074"},{"key":"1487_CR3","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1001\/jama.2018.3394","volume":"319","author":"G Peltz","year":"2018","unstructured":"Peltz G, Sudhof TC. The neurobiology of opioid addiction and the potential for prevention strategies. JAMA. 2018;319:2071\u20132.","journal-title":"JAMA"},{"key":"1487_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/FPC.0b013e328322e73d","volume":"19","author":"LF Chu","year":"2009","unstructured":"Chu LF, Liang DY, Li X, Sahbaie P, D\u2019arcy N, Liao G, et al. From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. Pharmacogenet Genomics. 2009;19:193\u2013205.","journal-title":"Pharmacogenet Genomics"},{"key":"1487_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/00952990.2016.1210614","volume":"43","author":"MJ Erlendson","year":"2017","unstructured":"Erlendson MJ, D\u2019Arcy N, Encisco EM, Yu JJ, Rincon-Cruz L, Peltz G, et al. Palonosetron and hydroxyzine pre-treatment reduces the objective signs of experimentally-induced acute opioid withdrawal in humans: a double-blinded, randomized, placebo-controlled crossover study. Am J Drug Alcohol Abus. 2017;43:78\u201386.","journal-title":"Am J Drug Alcohol Abus"},{"key":"1487_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cpt.5","volume":"97","author":"MH Elkomy","year":"2015","unstructured":"Elkomy MH, Sultan P, Carvalho B, Peltz G, Wu M, Clavijo C, et al. Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndrome. Clin Pharm Ther. 2015;97:167\u201376.","journal-title":"Clin Pharm Ther"},{"key":"1487_CR7","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41372-018-0174-z","volume":"38","author":"HE Jones","year":"2018","unstructured":"Jones HE, O\u2019Grady KE, Kaltenbach K. Reconsidering retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome. J Perinatol. 2018;38:1280\u20131.","journal-title":"J Perinatol"},{"key":"1487_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41372-018-0088-9","volume":"38","author":"SL Merhar","year":"2018","unstructured":"Merhar SL, McAllister JM, Wedig-Stevie KE, Klein AC, Meinzen-Derr J, Poindexter BB. Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome. J Perinatol. 2018;38:587\u201392.","journal-title":"J Perinatol"},{"key":"1487_CR9","doi-asserted-by":"publisher","unstructured":"Oei JL, Melhuish E, Uebel H, Azzam N, Breen C, Burns L, et al. Neonatal Abstinence Syndrome and High School Performance. Pediatrics 2017;139: https:\/\/doi.org\/10.1542\/peds.2016-2651.","DOI":"10.1542\/peds.2016-2651"},{"key":"1487_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0378-4274(02)00505-2","volume":"140-141","author":"A Ornoy","year":"2003","unstructured":"Ornoy A. The impact of intrauterine exposure versus postnatal environment in neurodevelopmental toxicity: long-term neurobehavioral studies in children at risk for developmental disorders. Toxicol Lett. 2003;140-141:171\u201381.","journal-title":"Toxicol Lett"},{"key":"1487_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.earlhumdev.2007.01.013","volume":"84","author":"RW Hunt","year":"2008","unstructured":"Hunt RW, Tzioumi D, Collins E, Jeffery HE. Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. Early Hum Dev. 2008;84:29\u201335.","journal-title":"Early Hum Dev"},{"key":"1487_CR12","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/cpt.1064","volume":"103","author":"JN Moore","year":"2018","unstructured":"Moore JN, Gastonguay MR, Ng CM, Adeniyi-Jones SC, Moody DE, Fang WB, et al. The pharmacokinetics and pharmacodynamics of buprenorphine in neonatal abstinence syndrome. Clin Pharm Ther. 2018;103:1029\u201337.","journal-title":"Clin Pharm Ther"},{"key":"1487_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000227054","volume":"49","author":"MB Tyers","year":"1992","unstructured":"Tyers MB, Freeman AJ. Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists. Oncology. 1992;49:263\u20138.","journal-title":"Oncology"},{"key":"1487_CR14","first-page":"S12","volume":"19","author":"MB Tyers","year":"1992","unstructured":"Tyers MB. Site(s) and mechanisms of the anti-emetic action of 5-HT3 receptor antagonists: a discussion of Professor Naylor\u2019s paper. Br J Cancer Suppl. 1992;19:S12\u20133.","journal-title":"Br J Cancer Suppl"},{"key":"1487_CR15","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jpainsymman.2007.12.005","volume":"35","author":"RK Portenoy","year":"2008","unstructured":"Portenoy RK, Thomas J, Moehl Boatwright ML, Tran D, Galasso FL, Stambler N, et al. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manag. 2008;35:458\u201368.","journal-title":"J Pain Symptom Manag"},{"key":"1487_CR16","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1056\/NEJMoa0707377","volume":"358","author":"J Thomas","year":"2008","unstructured":"Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med. 2008;358:2332\u201343.","journal-title":"N Engl J Med"},{"key":"1487_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/BF02247730","volume":"109","author":"KH Simpson","year":"1992","unstructured":"Simpson KH, Murphy P, Colthup PV, Whelan P. Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers. Psychopharmacol (Berl). 1992;109:497\u20138.","journal-title":"Psychopharmacol (Berl)"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-022-01487-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-022-01487-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-022-01487-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T15:04:48Z","timestamp":1678201488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-022-01487-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,27]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1487"],"URL":"https:\/\/doi.org\/10.1038\/s41372-022-01487-2","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,27]]},"assertion":[{"value":"24 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}